Singapore markets closed

Cano Health, Inc. (CANO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.4900+0.1200 (+8.76%)
At close: 04:00PM EST
1.5100 +0.02 (+1.34%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 3-76.35%
S&P500 52-week change 3-7.75%
52-week high 39.7500
52-week low 30.9800
50-day moving average 31.3808
200-day moving average 34.5109

Share statistics

Avg vol (3-month) 310.78M
Avg vol (10-day) 36.06M
Shares outstanding 5244.57M
Implied shares outstanding 6N/A
Float 8195.79M
% held by insiders 130.52%
% held by institutions 168.43%
Shares short (12 Jan 2023) 426.67M
Short ratio (12 Jan 2023) 42.83
Short % of float (12 Jan 2023) 417.55%
Short % of shares outstanding (12 Jan 2023) 410.91%
Shares short (prior month 14 Dec 2022) 422.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin -2.28%
Operating margin (ttm)-3.83%

Management effectiveness

Return on assets (ttm)-2.82%
Return on equity (ttm)-15.38%

Income statement

Revenue (ttm)2.55B
Revenue per share (ttm)12.57
Quarterly revenue growth (yoy)33.30%
Gross profit (ttm)198.97M
EBITDA -18.03M
Net income avi to common (ttm)-58.24M
Diluted EPS (ttm)-0.6700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.1M
Total cash per share (mrq)0.1
Total debt (mrq)1.11B
Total debt/equity (mrq)141.88
Current ratio (mrq)1.64
Book value per share (mrq)1.70

Cash flow statement

Operating cash flow (ttm)-118.19M
Levered free cash flow (ttm)-10.38M